With reference to earlier letter dated 25-May-23 on the inspection conducted by USFDA for our Manufacturing facility at Dahej, Gujarat from 17-May-23 to 25-May-23, Torrent Pharmaceuticals has informed that the USFDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility and the inspection has now been successfully closed by the USFDA.
The above information is a part of company’s filings submitted to BSE.